相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II
Torayuki Okuyama et al.
MOLECULAR THERAPY (2021)
Identification and Functional Characterization of IDS Gene Mutations Underlying Taiwanese Hunter Syndrome (Mucopolysaccharidosis Type II)
Hsiang-Yu Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B
Harrison C. Brown et al.
HUMAN GENE THERAPY (2020)
Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation
Miho Wada et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management
Jing Zhou et al.
INTRACTABLE & RARE DISEASES RESEARCH (2020)
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles
Laura Rigon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
Torayuki Okuyama et al.
MOLECULAR THERAPY (2019)
Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease
Silvin Lito et al.
STEM CELL RESEARCH (2019)
Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene
Yanmin Zhang et al.
STEM CELL RESEARCH (2019)
A Sendai Virus-Based Cytoplasmic RNA Vector as a Novel Platform for Long-Term Expression of MicroRNAs
Masayuki Sano et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Direct&IT In Vivo&IT Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial Infarction
Kazutaka Miyamoto et al.
CELL STEM CELL (2018)
Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms
Helene F. E. Gleitz et al.
EMBO MOLECULAR MEDICINE (2018)
A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
Hiroyuki Sonoda et al.
MOLECULAR THERAPY (2018)
Targeting Root Cause by Systemic scAAV9-h/DS Gene Delivery: Functional Correction and Reversal of Severe MPS II in Mice
Haiyan Fu et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors
Koichiro Nishino et al.
REGENERATIVE THERAPY (2018)
Quantification of 11 enzyme activities of lysosomal storage disorders using liquid chromatography-tandem mass spectrometry
Mari Ohira et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2018)
Quantification of the enzyme activities of iduronate-2-sulfatase, N-acetylgalactosamine-6-sulfatase and N-acetylgalactosamine-4-sulfatase using liquid chromatography-tandem mass spectrometry
Ryuichi Mashima et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2018)
Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)
Galina V. Ilyinskaya et al.
FRONTIERS IN VETERINARY SCIENCE (2018)
Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2017)
Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry
Joseph Muenzer et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302
Ken Nishimura et al.
STEM CELL RESEARCH (2017)
Insights into Hunter syndrome from the structure of iduronate-2-sulfatase
Mykhaylo Demydchuk et al.
NATURE COMMUNICATIONS (2017)
Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation
Ken Nishimura et al.
STEM CELL REPORTS (2017)
Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction
Daigo Hasegawa et al.
PLOS ONE (2017)
A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
Joseph Muenzer et al.
GENETICS IN MEDICINE (2016)
Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice
Christian Hinderer et al.
HUMAN GENE THERAPY (2016)
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase
Motomichi Kosuga et al.
MOLECULAR GENETICS AND METABOLISM (2016)
CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)
Sandra Motas et al.
JCI INSIGHT (2016)
Safety and Immunogenicity of an Intranasal Sendai Virus-Based Human Parainfluenza Virus Type 1 Vaccine in 3-to 6-Year-Old Children
Elisabeth Adderson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome
Yo Kyung Chung et al.
GLYCOCONJUGATE JOURNAL (2014)
Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp)
Shiho Kawagoe et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine
Mahito Nakanishi et al.
CURRENT GENE THERAPY (2012)
Development of Defective and Persistent Sendai Virus Vector A UNIQUE GENE DELIVERY/EXPRESSION SYSTEM IDEAL FOR CELL REPROGRAMMING
Ken Nishimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
IDS Crossing of the Blood-Brain Barrier Corrects CNS Defects in MPSII Mice
Vinicia Assunta Polito et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Newborn screening for Pompe disease by measuring acid α-glucosidase activity using tandem mass spectrometry
Angela Dajnoki et al.
CLINICAL CHEMISTRY (2008)
Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes
Alessandro Fraldi et al.
HUMAN MOLECULAR GENETICS (2007)
Persistent and stable gene expression by a cytoplasmic RNA replicon based on a noncytopathic variant Sendai virus
Ken Nishimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase A efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy
Toshiyuki Kurai et al.
MOLECULAR THERAPY (2007)
Naked Sendai virus vector tacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity
Mariko Yoshizaki et al.
JOURNAL OF GENE MEDICINE (2006)
Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme
T Dierks et al.
CELL (2005)
Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases
H Kinoh et al.
GENE THERAPY (2004)
Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells
M Bitzer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Efficient gene transfer to airway epithelium using recombinant Sendai virus
Y Yonemitsu et al.
NATURE BIOTECHNOLOGY (2000)
分享论文
